Urinary tract infection in patients with lower urinary tract dysfunction

J Infect Chemother. 2023 Aug;29(8):744-748. doi: 10.1016/j.jiac.2023.04.019. Epub 2023 May 5.

Abstract

Lower urinary tract dysfunction (LUTD) is becoming more common in aging societies worldwide. In patients with LUTD, the risk of urinary tract infection (UTI) rises due to several distinct mechanisms, including easy bacterial access to the urinary tract, impaired bacterial washout, and an impaired innate defense system. The pathophysiology of LUTD varies depending on whether it is neurogenic or non-neurogenic, as well as by gender; therefore, the etiology and characteristics of UTI differ according to the type of LUTD. Patients with neurogenic LUTD, especially those with spinal cord injury, have a high risk of febrile UTI, and strict bladder management is required to prevent UTI. Clean intermittent catheterization with or without appropriate pharmacological therapy is also strongly recommended for patients with neurogenic LUTD at risk of febrile UTI, unable to void, or with high post-void residual volume. In contrast, both male and female patients with non-neurogenic LUTD have a lower risk of symptomatic UTI. There is insufficient evidence for non-neurogenic LUTD regarding the association between symptomatic UTI but not asymptomatic bacteriuria and LUTD severity, including the presence of post-void residual volume, or whether therapeutic intervention for LUTS reduces the incidence of UTI, particularly in male patients. In this narrative review, we aimed to highlight the pathogenesis, epidemiology, and management of UTI in patients with LUTD.

Keywords: Bacteriuria; Intermittent catheterization; Lower urinary tract symptoms; Neurogenic bladder; Urinary incontinence; Urinary tract infection.

Publication types

  • Review

MeSH terms

  • Bacteriuria* / etiology
  • Female
  • Humans
  • Intermittent Urethral Catheterization* / adverse effects
  • Male
  • Risk Factors
  • Urinary Bladder
  • Urinary Bladder, Neurogenic* / complications
  • Urinary Bladder, Neurogenic* / therapy
  • Urinary Tract Infections* / complications
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / epidemiology